USD 50 billion commitment includes new state-of-the art research and development (R&D) sites, new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California and
Transaction further establishes Norgine’s position as a partner of choice for commercialising rare and specialty pharmaceuticals in Europe Norgine and Theravia announced that they have entered into
Azurity Pharmaceuticals announced the successful completion of its acquisition of Covis Group from existing investors. With this acquisition, Covis is now a wholly-owned subsidiary of
Vizient, Inc., the nation’s largest healthcare performance improvement company, announced it has renewed its agreement with TPC, a network of independent health systems in Texas
Fuel up with free Health Tech Insights
